Atlas Trials

Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Clinical trial NCT04233697 · WITHDRAWN

Trial details

NCT number
NCT04233697
Sponsor
Columbia University
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma, T-Cell
Start date
2020-02-01
Primary completion
2022-07-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.